Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xiajing Gu"'
Autor:
Lei Fu, Miao Lin, Shan Cong, Mingwang Li, Chenchen Fan, Xiajing Gu, Zhigang Zhao, Yuanyuan Qiu, Zeyu Xiao, Gaoxian Chen, Xiaohong Fang
Publikováno v:
ACS Applied Materials & Interfaces. 11:23436-23444
Surface-enhanced Raman scattering (SERS) probes have exhibited great potential in biomedical applications. However, currently reported SERS probes are mainly fabricated by nondegradable Au or Ag nanostructures, which are not favorably cleared from th
Autor:
Xiajing Gu, Yingzhi Chen, Miao Lin, Yuanyuan Qiu, Yongming Zhang, Kai Cui, Zeyu Xiao, Gaoxian Chen, Lu Xu, Wei Lu, Chenchen Fan, Hong-Zhuan Chen, Jian-Bo Wan
Publikováno v:
Nano Letters. 19:3344-3352
Bypass signaling activation plays a crucial role in the acquired resistance of gefitinib, the first targeted drug in the clinic to treat advanced non-small cell lung cancer. Although the inactivation of bypass signaling by small-molecule inhibitors o
Autor:
Zeyu Xiao, Lei Lu, Dehui Hu, Mingwang Li, Xiajing Gu, Dianhua Liu, Gaoxian Chen, Yuanyuan Qiu
Publikováno v:
Science Bulletin. 61:670-681
Colon-targeted oral delivery is crucial for the treatment of colon-related diseases, as this delivery strategy enables precise drug administration to the diseased site, enhances drug bioavailability, and improves patient compliance. In particular, na
Publikováno v:
Cancer Biology & Therapy. 16:634-643
Lung cancers express non-neuronal, cholinergic autoparacrine loop, which facilitates tumor growth. Interruption of M3 muscarinic cholinergic signaling has been reported to inhibit small cell lung cancer (SCLC) growth. The purpose of this study is to
Publikováno v:
Oncotarget
// Ling Li 1, * , Xiajing Gu 1, * , Jinnan Yue 1 , Qingnan Zhao 1 , Dacheng Lv 1 , Hongzhuan Chen 1 and Lu Xu 1 1 Department of Pharmacology, Shanghai Jiao Tong University School of Medicine, Shanghai, China * These authors have contributed equally t
Publikováno v:
Oncotarget
Non-neuronal cholinergic system is involved in lung physiology and lung cancer. However, the biochemical events downstream acetylcholine (ACh) receptor activation leading to carcinogenesis and tumor progression are not fully understood. Our previous